Literature DB >> 2192879

Dyslipoproteinemia in women. Special considerations.

V T Miller1.   

Abstract

Heart disease is the number one cause of death in women, as it is in men; risk factors include high cholesterol, high triglycerides, low HDL-C, diabetes, hypertension, and cigarette smoking. Most of these factors are alterable. The lipoprotein profile of a woman undergoes many changes during her lifetime because of the effects of endogenous hormones at pregnancy, the administration of oral contraceptives, and estrogen replacement at the menopause. Endogenous estrogen reduces the risk of heart disease in women as does unopposed estrogen replacement in the menopause. Oral contraceptives, on the other hand, can increase risk depending on the dose prescribed. Careful attention to a woman's native lipid profile, as well as to the impact of administered hormones on her lipids, is important. It is the responsibility of the physician to help patients achieve and maintain the least atherogenic lipid profile possible as well as to identify and reduce other cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2192879

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  6 in total

Review 1.  Sex steroids and the cardiovascular system.

Authors:  C Christiansen
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  Use of lipid-lowering agents (statins) during pregnancy.

Authors:  Akiko Hosokawa; Benjamin Bar-Oz; Shinya Ito
Journal:  Can Fam Physician       Date:  2003-06       Impact factor: 3.275

Review 3.  The metabolic syndrome in women.

Authors:  Rhonda Bentley-Lewis; Katherine Koruda; Ellen W Seely
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-10

4.  Long-term plasma lipid changes associated with a first birth: the Coronary Artery Risk Development in Young Adults study.

Authors:  Erica P Gunderson; Cora E Lewis; Maureen A Murtaugh; Charles P Quesenberry; Delia Smith West; Stephen Sidney
Journal:  Am J Epidemiol       Date:  2004-06-01       Impact factor: 4.897

5.  The impact of maternal obesity and gestational weight gain on early and mid-pregnancy lipid profiles.

Authors:  Christina M Scifres; Janet M Catov; Hyagriv N Simhan
Journal:  Obesity (Silver Spring)       Date:  2013-12-02       Impact factor: 5.002

6.  Risk of congenital anomalies in pregnant users of statin drugs.

Authors:  Benjamin Ofori; Evelyne Rey; Anick Bérard
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.